Intercept Pharmaceuticals Inc (ICPT)

37.27 -0.12  -0.32% NASDAQ Nov 27, 20:00 USD

Intercept Pharmaceuticals Gross Profit Margin (Quarterly):

97.70% for Sept. 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Gross Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Gross Profit Margin (Quarterly) Data

View and export this data going back to 2017. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2020 97.70%
June 30, 2020 97.57%
March 31, 2020 98.83%
Dec. 31, 2019 96.54%
Sept. 30, 2019 99.21%
June 30, 2019 98.98%
March 31, 2019 98.90%
Dec. 31, 2018 98.11%
   
Sept. 30, 2018 98.90%
June 30, 2018 98.36%
March 31, 2018 99.22%
Dec. 31, 2017 97.82%
Sept. 30, 2017 99.58%
June 30, 2017 99.10%
March 31, 2017 99.54%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Benchmarks

Zosano Pharma Corp --
Biomarin Pharmaceutical Inc 60.40%
Celsion Corp --

Gross Profit Margin (Quarterly) Range, Past 5 Years

Minimum 96.54% Dec 2019
Maximum 99.58% Sep 2017
Average 98.56%

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.